Current situation of drug-resistant tuberculosis in Mongolia
- VernacularTitle:Монгол дахь олон эмэнд дасалтай сүрьеэгийн байдал
- Author:
Naranbat N
1
;
Narantuya J
;
Ganzaya S
Author Information
1. Health Sciences University of Mongolia
- Publication Type:Journal Article
- Keywords:
MDR;
TB;
TB drug;
- From:Mongolian Medical Sciences
2010;153(3):76-77
- CountryMongolia
- Language:Mongolian
-
Abstract:
Since 1994 when Directly Observed Therapy Short Course (DOTS) was first introduced in TB control in Mongolia, the National TB Programme has made significant progress in detecting and curing TB. In 2007, we were able to detect 81% of all TB cases and cure 88%. However, we face many obstacles and challenges in dealing with drug-resistant tuberculosis including limited access to multi-drug resistant TB treatment, limited supply of second-line drugs, limited capacity of service providers, poor infection control in health facilities dealing with MDR-TB patients, limited financial resources. Since 2006 Mongolia has started to implement project on multi-drug resistant TB (MDR-TB) management through support of the Global Fund to Fight AIDS, Tuberculosis and Malaria. In total, 888 cases of drug-resistant TB were detected in our country. Among them, 66.3% (589) were diagnosed with MDR-TB. Among 589 MDR-TB cases diagnosed between 2003-2009, 45.3% (267) are enrolled in treatment, 26.7% (157) died before enrollment into treatment, 19.7% (116) are on waiting list. If we do not improve supply of second-line drugs we will continue to face obstacles in provision of medical services to MDR-TB patients. Our data shows that although MDR-TB cases were diagnosed in 2006, the number of patients who would not be able to receive the treatment and would die by 2015 would increase up to 510 persons. In other words, although about 70 patients are diagnosed every year, they would not be able to receive treatment. Mobilization of 350 thousand US dollars every year and advocacy among decision makers in order to improve their commitment will contribute to fight against MDR-TB in our country.
